Company / Accounts Receivable
SI-BONE, Inc. Accounts Receivable History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$29.9M
FY2025
5-year range
$14.2M / $29.9M
FY2021-FY2025
Trend
+8.9%
vs FY2024
Sector context
#129 of 143
Health Care
What the data says
Among 143 Health Care companies, SI-BONE, Inc. is in the bottom 10% for accounts receivable. Accounts Receivable has increased for 8 consecutive years, from $7M in FY2017 to $30M in FY2025.
Based on SEC 10-K filings.
$30M in FY2025 with a 5-year CAGR of +17.1%.
Improved from $22M to $30M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +13.1%
- 5-Year CAGR
- +17.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 143This company $29.9M Sector average $1.3B
▼
-97.8% below sector average
Key checks
Key Insights
- SI-BONE, Inc.'s accounts receivable has grown for 8 consecutive years.
- 5-year CAGR of +17.1%, indicating consistent growth.
- In FY2025, accounts receivable increased 8.9% year-over-year.
- Ranks #129 out of 143 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- Negative profit margin: -18.5%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.9M | +8.9% |
| FY2024 | $27.5M | +25.1% |
| FY2023 | $22.0M | +6.2% |
| FY2022 | $20.7M | +45.1% |
| FY2021 | $14.2M | +4.7% |
| FY2020 | $13.6M | +16.1% |
| FY2019 | $11.7M | +38.1% |
| FY2018 | $8.5M | +14.4% |
| FY2017 | $7.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026